MetLife (NYSE: MET) account plans 68-share NYSE common stock sale
Rhea-AI Filing Summary
A MetLife-related account filed a notice of proposed sale of 68 shares of common stock, to be sold through Bernstein Institutional Services LLC on the NYSE. The shares have an indicated aggregate market value of $5,556.28, while the filing notes that 658,891,656 common shares are outstanding. The seller acquired these 68 shares by purchase from Deutsche Bank on June 28, 2013, with cash payment on July 3, 2013. The notice also lists several small common stock sales by various MetLife separate accounts and retirement plans over the prior three months, each showing the number of shares sold and gross proceeds. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
FAQ
What does the latest Form 144 filing for MET disclose?
The filing discloses that a MetLife-related account intends to sell 68 shares of common stock on the NYSE through Bernstein Institutional Services LLC, with an indicated aggregate market value of $5,556.28.
What recent MET stock sales by MetLife accounts are listed in the Form 144?
The filing lists several small common stock sales over the past three months by MetLife separate accounts and retirement plans, including transactions such as 64 shares sold for $5,066.24 and 333 shares sold for $27,282.69, each showing the seller name, sale date, number of shares, and gross proceeds.
What representation does the seller make in this MET Form 144 filing?
By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.